The group reported substantial sales, profits and earnings growth, all at record levels. Before on...
The group reported substantial sales, profits and earnings growth, all at record levels. Before one-off costs profit before tax was up 79% and sales by over 60% as the company focused on the speciality pharmaceuticals sector and its acquisition of the French pharma business, Martindale.
Following this acquisition the group has divided its activities into pharmaceutical distribution and manufacturing. As well as strong organic growth, the group will continue to look for further significantly sized acquisitions in the UK and overseas.
Clients to be compensated by end of 2018
Rolled out to 25 schemes next month
Mean gender pay gap now 16.64%
26 years in financial services
Some 150 claims still to process